Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Bloomberg) Dec 22, 2014 - Bristol-Myers Squibb Co. won U.S. approval to sell its drug Opdivo for advanced melanoma, part of a line of new treatments that use patients’ immune systems against cancer.
read article »
(Medscape Medical News) Dec 22, 2014 - The UK healthcare watchdog says that two prostate cancer tests for use in inconclusive cases do not improve diagnosis enough to justify use in clinical practice.
read article (free registration required) »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
OBR Job Board
NCCN has posted 1 new job.
Bayer Biopharmaceuticals, Inc. has posted 20 jobs.
Ipsen Biopharmaceuticals, Inc. has posted over 50 jobs.